We are live on ! Find out more
HLVX

HilleVax

Delisted

HLVX was delisted on the 16th of September, 2025.

54 hedge funds and large institutions have $437M invested in HilleVax in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 29 increasing their positions, 9 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

222% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 9

0% more capital invested

Capital invested by funds: $436M → $437M (+$400K)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

2.47% less ownership

Funds ownership: 67.28%64.81% (-2.5%)

11% less funds holding

Funds holding: 6154 (-7)

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

Holders
54
Holders Change
-7
Holders Change %
-11.48%
% of All Funds
0.85%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.06%
New
5
Increased
29
Reduced
9
Closed
11
Calls
Puts
Net Calls
Net Calls Change

HLVX Hedge Fund Activity: Q2 2023 in Review

54 of the 6,370 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q2 2023, worth a combined $437M — up 0.09% from $436M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of HLVX and 5 opened new positions — a net loss of 6 holders — while 9 trimmed existing stakes and 29 added.

The largest buyer was Deerfield Management, adding an estimated $7.68M. The largest seller was RA Capital Management, exiting entirely with an estimated $29.1M sold.

  • 54 institutional investors held HilleVax (HLVX) as of Q2 2023, down from 61 in Q1 2023.
  • Funds reported $437M of HilleVax stock for Q2 2023, up 0.09% quarter-over-quarter.
  • 5 funds opened new HilleVax positions in Q2 2023 and 11 closed out, a net change of -6 holders.
  • The largest HilleVax buyer in Q2 2023 was Deerfield Management, an estimated $7.68M added.
  • The largest HilleVax seller in Q2 2023 was RA Capital Management, an estimated $29.1M sold.

Based on aggregated 13F filings for Q2 2023.